QCM
AUPH icon

Quantinno Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Quantinno Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
89,794
+2,180
+2% +$34.8K ﹤0.01% 2205
2026
Q1 		$1.3M Buy
87,614
+5,285
+6% +$77.2K ﹤0.01% 1944
2025
Q4 		$1.31M Buy
82,329
+452
+0.6% +$6.41K ﹤0.01% 1587
2025
Q3 		$905K Sell
81,877
-4,592
-5% -$50.2K ﹤0.01% 1551
2025
Q2 		$732K Buy
+86,469
New +$693K ﹤0.01% 1431

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's AUPH Position: Q2 2026 in Review

Quantinno Capital Management increased its Aurinia Pharmaceuticals (AUPH) stake by 2.5% in Q2 2026, buying an estimated $34.8K and bringing the position to 89,794 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2205.

Quantinno Capital Management first reported a position in AUPH in Q2 2025 and has held it in 5 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Quantinno Capital Management held 89,794 shares of Aurinia Pharmaceuticals worth $1.52M as of Q2 2026.
  • Quantinno Capital Management bought 2,180 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $34.8K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2205 holding.
  • Quantinno Capital Management first reported a position in Aurinia Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.